The estimated Net Worth of Mayu Sris is at least $11.7 millier dollars as of 13 January 2017. Mayu Sris owns over 9,722 units of VIVUS stock worth over $11,663 and over the last 9 years Mayu sold VVUS stock worth over $0.
Mayu has made over 6 trades of the VIVUS stock since 2016, according to the Form 4 filled with the SEC. Most recently Mayu exercised 9,722 units of VVUS stock worth $4,535 on 13 January 2017.
The largest trade Mayu's ever made was exercising 9,722 units of VIVUS stock on 13 January 2017 worth over $4,535. On average, Mayu trades about 980 units every 9 days since 2015. As of 13 January 2017 Mayu still owns at least 25,001 units of VIVUS stock.
You can see the complete history of Mayu Sris stock trades at the bottom of the page.
Mayu's mailing address filed with the SEC is C/O VIVUS, INC., 351 EAST EVELYN AVENUE, MOUNTAIN VIEW, CA, 94041.
Over the last 21 years, insiders at VIVUS have traded over $6,261,269 worth of VIVUS stock and bought 5,180,746 units worth $13,074,554 . The most active insiders traders include Tide Capital, Llc North Tid..., Alexander J Denner et Ernest Mario. On average, VIVUS executives and independent directors trade stock every 39 days with the average trade being worth of $35,394. The most recent stock trade was executed by John P. Amos on 1 March 2019, trading 11,000 units of VVUS stock currently worth $53,350.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm's products are indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and is headquartered in Campbell, CA.
VIVUS executives and other stock owners filed with the SEC include: